American International Group’s Amedisys AMED Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q2
Sell
-43,192
Closed -$3.98M 139
2024
Q1
$3.98M Sell
43,192
-882
-2% -$82.7K 0.01% 814
2023
Q4
$4.19M Sell
44,074
-1,897
-4% -$177K 0.02% 786
2023
Q3
$4.29M Sell
45,971
-3,172
-6% -$293K 0.03% 746
2023
Q2
$4.49M Sell
49,143
-986
-2% -$80.9K 0.03% 761
2023
Q1
$3.69M Sell
50,129
-470
-0.9% -$40.7K 0.02% 813
2022
Q4
$4.23M Sell
50,599
-592
-1% -$53.4K 0.03% 760
2022
Q3
$4.96M Sell
51,191
-2,621
-5% -$313K 0.04% 666
2022
Q2
$5.66M Sell
53,812
-1,653
-3% -$211K 0.04% 660
2022
Q1
$9.56M Buy
55,465
+104
+0.2% +$15.5K 0.05% 486
2021
Q4
$8.96M Sell
55,361
-1,073
-2% -$172K 0.04% 552
2021
Q3
$8.41M Sell
56,434
-1,667
-3% -$347K 0.04% 556
2021
Q2
$14.2K Sell
58,101
-1,755
-3% -$460K 0.05% 347
2021
Q1
$15.8K Buy
59,856
+273
+0.5% +$77K 0.06% 290
2020
Q4
$17.5K Sell
59,583
-331
-0.6% -$84.9K 0.06% 239
2020
Q3
$14.2M Sell
59,914
-1,023
-2% -$233K 0.07% 228
2020
Q2
$12.1M Sell
60,937
-20,010
-25% -$3.73M 0.06% 255
2020
Q1
$14.9M Sell
80,947
-442
-0.5% -$78.6K 0.08% 178
2019
Q4
$13.6M Buy
81,389
+377
+0.5% +$56.1K 0.05% 288
2019
Q3
$10.6M Buy
81,012
+4,563
+6% +$594K 0.04% 373
2019
Q2
$9.28M Buy
76,449
+1,808
+2% +$215K 0.04% 436
2019
Q1
$9.2M Buy
74,641
+53,620
+255% +$6.73M 0.04% 451
2018
Q4
$2.46M Sell
21,021
-249
-1% -$29.3K 0.01% 911
2018
Q3
$2.66M Sell
21,270
-775
-4% -$85.6K 0.01% 948
2018
Q2
$1.88M Buy
22,045
+3,827
+21% +$281K 0.01% 1049
2018
Q1
$1.1M Sell
18,218
-4,440
-20% -$253K ﹤0.01% 1220
2017
Q4
$1.19M Buy
22,658
+98
+0.4% +$5.17K ﹤0.01% 1262
2017
Q3
$1.26M Buy
22,560
+1,285
+6% +$68K ﹤0.01% 1211
2017
Q2
$1.34M Buy
21,275
+4,056
+24% +$236K ﹤0.01% 1117
2017
Q1
$880K Sell
17,219
-3,260
-16% -$155K ﹤0.01% 1262
2016
Q4
$873K Sell
20,479
-297
-1% -$12.6K ﹤0.01% 1309
2016
Q3
$986K Sell
20,776
-54
-0.3% -$2.69K ﹤0.01% 1224
2016
Q2
$1.05M Sell
20,830
-3,094
-13% -$156K ﹤0.01% 1145
2016
Q1
$1.16M Buy
23,924
+3,553
+17% +$137K ﹤0.01% 1410
2015
Q4
$801K Buy
20,371
+222
+1% +$8.88K ﹤0.01% 1639
2015
Q3
$766K Sell
20,149
-537
-3% -$22.6K ﹤0.01% 1646
2015
Q2
$822K Sell
20,686
-623
-3% -$19.4K ﹤0.01% 1742
2015
Q1
$571K Buy
21,309
+203
+1% +$5.73K ﹤0.01% 2050
2014
Q4
$619K Sell
21,106
-583
-3% -$14.4K ﹤0.01% 1953
2014
Q3
$437K Buy
21,689
+190
+0.9% +$3.67K ﹤0.01% 2260
2014
Q2
$360K Sell
21,499
-3,218
-13% -$45.6K ﹤0.01% 2459
2014
Q1
$368K Buy
24,717
+664
+3% +$10.2K ﹤0.01% 2322
2013
Q4
$352K Sell
24,053
-184
-0.8% -$2.96K ﹤0.01% 2290
2013
Q3
$417K Buy
24,237
+203
+0.8% +$3.01K ﹤0.01% 2108
2013
Q2
$279K Buy
+24,034
New +$275K ﹤0.01% 2292

Other funds holding AMED

American International Group's AMED Position: Q2 2024 in Review

American International Group sold out of Amedisys (AMED) in Q2 2024, closing a stake of 43,192 shares — an estimated $3.98M sold.

American International Group first reported a position in AMED in Q2 2013 and held it in 44 quarters. The position peaked at $14.9M in Q1 2020. 288 funds tracked by Wall St. Rank hold AMED as of Q2 2024.

  • American International Group reported no remaining Amedisys position as of Q2 2024 after selling out during the quarter.
  • American International Group sold 43,192 Amedisys shares in Q2 2024, an estimated $3.98M.
  • American International Group first reported a position in Amedisys in Q2 2013 and held it in 44 quarters.
  • American International Group's Amedisys position peaked at $14.9M in Q1 2020.
  • 288 funds tracked by Wall St. Rank held Amedisys as of Q2 2024.

Based on American International Group's 13F filing for Q2 2024, filed 13 Aug 2024.